Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abatacept”

216 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 216 results

Testing effectiveness (Phase 2)WithdrawnNCT04477642
What this trial is testing

Abatacept for Patients With COVID-19 and Respiratory Distress

Who this might be right for
COVID-19
Beth Israel Deaconess Medical Center
Early research (Phase 1)Study completedNCT00705367
What this trial is testing

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 13
Testing effectiveness (Phase 2)Ended earlyNCT04472494
What this trial is testing

Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise

Who this might be right for
COVID-19SARS-CoV-2
Bristol-Myers Squibb 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT05621759
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

Who this might be right for
Graft Vs Host Disease
NYU Langone Health 27
Testing effectiveness (Phase 2)Study completedNCT00254293
What this trial is testing

Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 87
Testing effectiveness (Phase 2)Ended earlyNCT00534313
What this trial is testing

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Bristol-Myers Squibb 191
Not applicableWithdrawnNCT02053727
What this trial is testing

Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background

Who this might be right for
Rheumatoid ArthritisChronic Hepatitis B
University of California, Los Angeles
Large-scale testing (Phase 3)Study completedNCT00122382
What this trial is testing

Remission and Joint Damage Progression in Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,052
Not applicableStudy completedNCT02885818
What this trial is testing

Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
University Hospital, Brest 20
Testing effectiveness (Phase 2)Study completedNCT00468403
What this trial is testing

LEA29Y (Belatacept) Emory Edmonton Protocol

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Looking for participantsNCT07599176
What this trial is testing

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Who this might be right for
Sickle Cell DiseaseBeta-thalassemia
National Heart, Lung, and Blood Institute (NHLBI) 90
Testing effectiveness (Phase 2)Study completedNCT02161406
What this trial is testing

Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna, MD, MS 88
Early research (Phase 1)UnknownNCT06395038
What this trial is testing

IL-2 Plus Abatacept in FTD

Who this might be right for
Frontotemporal Degeneration
The Methodist Hospital Research Institute 10
Not applicableStudy completedNCT03419143
What this trial is testing

Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants

Who this might be right for
Psoriatic Arthritis (PsA)
Bristol-Myers Squibb 190
Large-scale testing (Phase 3)UnknownNCT05451615
What this trial is testing

Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis

Who this might be right for
AbataceptTreatment ComplianceRheumatoid Arthritis
Zhejiang Provincial People's Hospital 90
Testing effectiveness (Phase 2)Study completedNCT02592798
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Who this might be right for
Nephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease
Bristol-Myers Squibb 36
Not applicableWithdrawnNCT01694693
What this trial is testing

Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT01557374
What this trial is testing

TOward the Lowest Effective DOse of Abatacept or Tocilizumab

Who this might be right for
Rheumatoid Arthritis
Assistance Publique - Hôpitaux de Paris 232
Not applicableStudy completedNCT02335606
What this trial is testing

Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 213
Not applicableStudy completedNCT02109666
What this trial is testing

Long Term Experience With Abatacept in Routine Clinical Practice

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 2,364
Next Page